US 11,629,124 B2Granted

Solid forms comprising an oxime ether compound, compositions and methods of use thereof

AssigneeNovartis AG

InventorsLianfeng Huang, Daozhong Zou

Life of this patent

Estimating the term…

Abstract

Provided herein are formulations, processes, solid forms and methods of use relating to (E)-1-(4-(1-(((4-cyclohexyl-3-(trifluoromethyl)benzyl)oxy)imino)ethyl)-2-ethylbenzyl)azetidine-3-carboxylic acid.

Claims10

Dependent claims

A solid form of (E)-1-(4-(1-(((4-cyclohexyl-3-(trifluoromethyl)benzyl)oxy)imino)ethyl)-2-ethylbenzyl)azetidine-3-carboxylic acid selected from the group consisting of Form A, Form B, Form C, Form H, Form I, Form F and mixtures of any of the foregoing.

Dependencies are inferred from the claim text.

Facts

Application: 16/752,041Filed 24 Jan 2020 · continuation
Priority: 9 Mar 2017
Published: US 2020/0399213 A124 Dec 2020
Granted: 18 Apr 2023
Term ends: Not estimatedThe source records don’t support an estimate.

Classification9 codes

C07D 205/04
Not condensed with other rings: having no double bonds between ring members or between ring members and non-ring members
A61K 9/20
Medicinal preparations characterised by special physical form: pills, tablets, discs, rods
A61K 9/2054
Polysaccharides, e.g. alginate, gums; Cyclodextrin: cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
A61K 9/48
Medicinal preparations characterised by special physical form: preparations in capsules, e.g. of gelatin, of chocolate

Family

Application62/469,150Us provisional application · filed 9 Mar 2017
Application62/591,880Us provisional application · filed 29 Nov 2017
Application15/916,015Parent of this continuation · filed 8 Mar 2018
US 2020/0399213 A1Pre-grant publication · published 24 Dec 2020
US 11,629,124 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results